Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Collaboration for Real-World Evidence in Alzheimer's Disease (ICARE AD)- A Prospective Real-World Observational Study of Aducanumab-avwa in Patients With Alzheimer's Disease in the US

NCT05097131 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT05097131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05097131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Collaboration for Real-World Evidence in Alzheimer's Disease (ICARE AD)- A Prospective Real-World Observational Study of Aducanumab-avwa in Patients With Alzheimer's Disease in the US
Lead sponsor
Biogen
Phase
Observational
Overall status
Terminated
Start date
November 18, 2021
Completion date
May 20, 2022
Enrollment
29 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimers disease